|Bid||17.73 x 900|
|Ask||17.75 x 4000|
|Day's Range||17.46 - 17.87|
|52 Week Range||8.86 - 32.48|
|Beta (5Y Monthly)||0.86|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Oct. 14, 1999|
|1y Target Est||N/A|
Rite Aid (RAD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Drugstore chain Rite Aid Corp said on Thursday it would be offering free COVID-19 tests to students in public schools in New York state before or at the start of the upcoming school year. The announcement comes as students in the United States prepare to head back to classes, while the country grapples with stemming the recent surge in cases caused by the Delta variant of the coronavirus. Rite Aid is conducting the testing drive in association with the U.S. Department of Health and Human Services, which in March said it would provide $10 billion to states to support COVID-19 screening to assist schools resume in-person instruction.
Shares of Rite Aid (NYSE: RAD) were gaining this week with the pharmacy stock up 9.7% through Thursday. There was no major news out on the drugstore chain, but the stock did seem to benefit from a short squeeze as shares spiked early in the week, even on Monday when stocks broadly pulled back. As the influence of traders on forums like Reddit's WallStreetBets has grown, it's not uncommon to see stocks with high short interest move higher with little explanation.